|
|
||||||||
dependent
Gastroenterology Section, Veterans Affairs Palo Alto Health Care System, Palo Alto 94304; and Division of Gastroenterology and Hepatology, Stanford University, Stanford, California 94305
Barrett's esophagus (BE) results from acid and bile reflux and predisposes to cancer. To further understand the mechanisms of acid- and bile-induced hyperproliferation in BE, we investigated the release of PGE2 in response to acid or bile salt exposure. Biopsies of esophagus, BE, and duodenum were exposed to a bile salt mixture as a 1-h pulse and compared with exposure to pH 7.4 for up to 24 h, and PGE2 release, cyclooxygenase-2 (COX-2), and protein kinase C (PKC) expression were compared. Similar experiments were also performed with acidified media (pH 3.5) alone, in the presence or absence of bisindolylmaleimide (BIM), a selective PKC inhibitor, and NS-398, a COX-2 inhibitor. One-hour pulses of bile salts or acid significantly enhanced proliferation, COX-2 expression, and PGE2 release in BE. In contrast, the combination pulse of acid and bile salts had no such effect. Treatment with either BIM or NS-398 led to a dramatic decrease in PGE2 release in BE explants and a suppression of proliferation. The acid- or bile salt-mediated hyperproliferation is related to PGE2 release. Acid- and bile salt-induced induction of COX-2 and PKC may explain, at least in part, the tumor-promoting effects of acid and bile in BE.
acid; bile salts; gastroesophageal reflux disease; protein kinase C; cyclooxygenase-2; prostaglandins; duodenogastric reflux
This article has been cited by other articles:
![]() |
G H Koek, D Sifrim, T Lerut, J Janssens, and J Tack Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus Gut, August 1, 2008; 57(8): 1056 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Song, S. Guha, K. Liu, N. S Buttar, and R. S Bresalier COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma Gut, November 1, 2007; 56(11): 1512 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Collins, T. Miyashita, M. Schweitzer, T. Magnuson, and J. W. Harmon Gastric Bypass: Why Roux-en-Y? A Review of Experimental Data Arch Surg, October 1, 2007; 142(10): 1000 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dvorak, M. Chavarria, C. M. Payne, L. Ramsey, C. Crowley-Weber, B. Dvorakova, B. Dvorak, H. Bernstein, H. Holubec, R. E. Sampliner, et al. Activation of the Interleukin-6/STAT3 Antiapoptotic Pathway in Esophageal Cells by Bile Acids and Low pH: Relevance to Barrett's Esophagus Clin. Cancer Res., September 15, 2007; 13(18): 5305 - 5313. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Zagorowicz and J. Jankowski Molecular changes in the progression of Barrett's oesophagus Postgrad. Med. J., August 1, 2007; 83(982): 529 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dvorak, C. M Payne, M. Chavarria, L. Ramsey, B. Dvorakova, H. Bernstein, H. Holubec, R. E Sampliner, N. Guy, A. Condon, et al. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus Gut, June 1, 2007; 56(6): 763 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lao-Sirieix, A. Roy, C. Worrall, S. L. Vowler, S. Gardiner, and R. C. Fitzgerald Effect of Acid suppression on molecular predictors for esophageal cancer. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 288 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jaiswal, C. Lopez-Guzman, R. F. Souza, S. J. Spechler, and G. A. Sarosi Jr Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line Am J Physiol Gastrointest Liver Physiol, February 1, 2006; 290(2): G335 - G342. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Suzuki, K Iijima, G Scobie, V Fyfe, and K E L McColl Nitrate and nitrosative chemistry within Barrett's oesophagus during acid reflux Gut, November 1, 2005; 54(11): 1527 - 1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H.-X. Xia, S. T. Zhang, S. K. Lam, M. C.-M. Lin, H. F. Kung, and B. C.-Y. Wong Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs Carcinogenesis, January 1, 2005; 26(1): 11 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Abdalla, P. Lao-Sirieix, M. R. Novelli, L. B. Lovat, I. R. Sanderson, and R. C. Fitzgerald Gastrin-Induced Cyclooxygenase-2 Expression in Barrett's Carcinogenesis Clin. Cancer Res., July 15, 2004; 10(14): 4784 - 4792. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |